Canalevia Ca1 Patent Expiration

Exclusivity Information

Canalevia Ca1 holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2028. Details of Canalevia Ca1's exclusivity codes and their expiration dates are given below.

Drug Exclusivity Drug Exclusivity Expiration
ODE Dec 21, 2028

About Canalevia Ca1

Canalevia Ca1 is a drug owned by JAGUAR ANIMAL HEALTH . Canalevia Ca1 uses Crofelemer as the active ingredient.

Active Ingredient:

Canalevia Ca1 uses Crofelemer as the active ingredient. Check out other Drugs and Companies using Crofelemer ingredient.